Perspectives on Enquiry & Evidence
Cytel's blog featuring the latest industry insights.
Featured post
Understanding Market Exclusivity for Orphan Drug Products
Market exclusivity for orphan drugs is a regulatory mechanism designed to incentivize pharmaceutical companies to develop treatments for rare diseases. This exclusivity grants the drug manufacturer a specific period during which no similar medicinal products can be approved for the same therapeutic indication, irrespective of patent status. This period provides a critical market advantage, allowing the company to recover the costs of research, development, and marketing without competitive products.
Clear Filters
Filter by
April 3, 2024
Thank you to Charlotta Gauffin, Chief Scientific Officer at Dicot, for joining us for our recent webinar, “The Road to...
Read article